LATEST NEWS: 23 October 2025 TROG Cancer Research has opened the new Australian arm of an international trial aimed at preventing skin cancer recurrence, following a groundbreaking collaboration with the US cancer clinical trials group, NRG Oncology. The NRG-HN014 trial is a phase III clinical trial targeting patients with
LATEST NEWS: 21 October 2025 Walking at least 10,000 steps – or about 7 km – each day isn’t a chore for 87-year-old grandad Mitch Cook, who’s clocking up the kilometres throughout October to support TROG’s inaugural “Km’s for Cancer Research” challenge. Mr Cook, from the small town of
To mark Prostate Cancer Month in September, we asked Chair of the TROG Genitourinary (GU) Working Party, Professor Wee Loon Ong, to share insights about his own research and how the Working Party is helping to progress research in this important area. Prof Ong is a Radiation Oncologist subspecialising
LATEST NEWS: 24 September 2025 TROG Cancer Research staff and many TROG Members celebrated World Radiotherapy Awareness Day (WRAD) throughout September, helping to spread the word about the vital impact of radiotherapy. The inaugural event held on 7 September, themed ‘One Voice for Radiotherapy’, was a great success in
LATEST NEWS: 24 September 2025 TROG is set to open the Australian arm of an international trial that aims to change practice in the treatment of high-risk prostate cancer, after the research team was awarded a $1.9 million Medical Research Future Fund (MRFF) Clinical Trials Activity grant. Marking a
LATEST NEWS: 16 September 2025 A ‘Talking Book’ which explains radiation therapy cancer treatment in a culturally-appropriate way for Aboriginal and Torres Strait Islander consumers is now available more broadly, after being updated for use on mobile devices. The book is the outcome of a Menzies School of Health
LATEST NEWS: 26 August 2025 The TROG Scientific Committee (TSC) has welcomed two new members, from the fields of radiation therapy and radiation oncology, supporting our work conducting high-quality, practice-changing clinical trials. The TSC, comprised of professionals from wide-ranging fields, plays a vital role in facilitating our work through
TRIAL UPDATE: 12 August 2025 Treating inoperable kidney cancer with Stereotactic Ablative Body Radiotherapy (SABR) is both more effective and less expensive than traditional ablative therapies in Australia, according to a new economic analysis of TROG 15.03/ANZUP 16001 FASTRACK II trial data. The findings of the economic evaluation, published
TROG WORKING PARTY IN FOCUS: 31 July 2025 To mark World Lung Cancer Day on 1 August, we asked Deputy Chair of the TROG Lung Working Party, Dr Yu Yang Soon, to share insights about his own research and how the Lung Working Party is helping to progress research
TRIAL IN FOCUS: 29 July 2025 We’ve extended the TROG 21.07 SOCRATES HCC trial recruitment period and are now seeking participants for the trial which could provide evidence for a new and more effective treatment option for patients with early-stage hepatocellular carcinoma (HCC). While curative surgical options are recommended
